Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Trial of the Efficacy and Safety of SPT-07A Injection in Patients With Acute Ischemic Stroke
Latest Information Update: 02 May 2023
Price :
$35 *
At a glance
- Drugs Borneol (Primary) ; Citicoline
- Indications Stroke
- Focus Therapeutic Use
- Acronyms SPAIR-2
- 26 Apr 2023 Planned End Date changed from 1 Jan 2024 to 10 Jan 2024.
- 26 Apr 2023 Planned primary completion date changed from 10 Jan 2023 to 10 Jan 2024.
- 27 Sep 2022 Planned primary completion date changed from 1 Jan 2022 to 10 Jan 2023.